Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/10/24 18:56 | 6/6/24 | KYTX | Health | BioPrd | Biological Products, (No Diag | Walker Karen Marie | CA | O | CTO | M.d | 43 | 4.42 | 0 | 10 | New | 10 | D | ||||||||||||||
5/29/24 16:33 | 5/28/24 | KYTX | Health | BioPrd | Biological Products, (No Diag | Jones Ryan Alexander | CA | O | CFO | M.d | 13 | 0.7300 | 0 | 18 | 69 | 44 | D | ||||||||||||||
2/14/24 19:04 | 2/12/24 | KYTX | Health | BioPrd | Biological Products, (No Diag | Vida Ventures, LLC | MA | T | P.d | 5,569 | 22.00 | 0 | 253 | 6 | 4,777 | I | |||||||||||||||
2/14/24 17:26 | 2/12/24 | KYTX | Health | BioPrd | Biological Products, (No Diag | Bain Capital Life Sciences Investors, LLC | MA | T | P.d | 9,900 | 22.00 | 0 | 450 | 17 | 3,164 | I | |||||||||||||||
2/13/24 17:48 | 2/12/24 | KYTX | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | P.d | 20,020 | 22.00 | 0 | 910 | 28 | 4,126 | D | |||||||||||||||
2/12/24 17:51 | 2/12/24 | KYTX | Health | BioPrd | Biological Products, (No Diag | Northpond Ventures III Gp, LLC | MD | H | Former 1 | P.d | 9,900 | 22.00 | 0 | 450 | 16 | 3,255 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |